SAT-094 Overweight and Obesity Associated with Immune-Related Adverse Events in Patients on Immune Checkpoint Inhibitor Therapy

Background As immune checkpoint inhibitor (ICI) therapies (PD(L)1 and CTLA-4 inhibitors) are increasingly used for treating malignancy, immune-related adverse events (irAEs) are being encountered by clinicians more frequently. Obesity is a pro-inflammatory metabolic state that has been associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Leiter, Amanda, Jia, Rachel, Carroll, Emily, Brooks, Danielle, Ben Shimol, Jennifer, Eisenberg, Elliot, Galsky, Matthew, Gallagher, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Adipose Tissue, Appetite, and Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552273/
http://dx.doi.org/10.1210/js.2019-SAT-094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552273/
http://dx.doi.org/10.1210/js.2019-SAT-094

Ejemplares similares